Capability details
EnGeneIC develops and commercializes novel concepts in the targeted delivery of chemotherapeutics for cancer drugs in-vivo. The company was incorporated in 2000 and is based in Lane Cove West, Australia. It serves customers in Australia, Singapore, Japan, and India.